home All News open_in_new Full Article

Arriva in Italia la prima monoterapia orale per l’emoglobinuria parossistica notturna di Novartis

Arriva in Italia la prima monoterapia orale per l’emoglobinuria parossistica notturna di Novartis  Milano Finanza


today 35 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 3367286169
Add Watch Country

arrow_drop_down